Delivery Order SPE2DB22D9130-SPE2DB25FE0FA
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, valued at $16,249.95, is scheduled for completion by August 20, 2025, with performance at the contractor's Park Ridge facility. The award carries no set-aside designation, reflecting the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/ml syringes valued at $16,249.95. The contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $32,499.90 for Stelara 90 mg/mL syringes under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a specific product delivery against the company's larger Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on July 17, 2025. The contract calls for delivery of Stelara 90 mg/ml syringes, a biologic medication used to treat immunological conditions, with an ultimate completion date of August 7, 2025. This delivery order carries no set-aside designation and will be performed at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award valued at approximately $195K for STELARA 90 MG/ML syringes from the Defense Logistics Agency's Medical Supply Chain on July 22, 2025. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's substantial...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for Stelara 90 mg/mL syringes. The award is issued under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/ml syringes. The award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/ml syringes. Awarded on September 17, 2025, with an ultimate completion date of October 8, 2025, this firm fixed-price delivery order carries no set-aside designation. The contract represents a direct procurement under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain division on July 11, 2025. The delivery order, issued under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare...
- SPE2DB22D9130Indefinite Delivery Contract
- SPE2DB22D9130-SPE2DB25FE0FADelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/ml syringes. The award, issued on July 14, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. This delivery order was issued without a set-aside designation, leveraging the company's competitive standing as a woman-owned small business in federal procurement markets. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency through the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a broad range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. Stelara, an immunosuppressant biologic used in treating various inflammatory conditions, represents one of the specialized pharmaceutical products within DMS Pharmaceutical Group's extensive federal portfolio, positioning the company as a critical supplier in the Department of Defense's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 7/14/25 |